Study suggests that strategic Wikipedia engagement enhances scientific visibility, highlighting new imperatives for AI-era information access
Peer-Reviewed Publication
This month, we’re focusing on artificial intelligence (AI), a topic that continues to capture attention everywhere. Here, you’ll find the latest research news, insights, and discoveries shaping how AI is being developed and used across the world.
Updates every hour. Last Updated: 30-Apr-2026 08:17 ET (30-Apr-2026 12:17 GMT/UTC)
Results of the single-center, phase 2 CAR-PRISM (PRecision Intervention Smoldering Myeloma) clinical trial, the first to investigate Chimeric Antigen Receptor (CAR) T-cell therapy in patients with high-risk smoldering multiple myeloma, showed that all 20 patients were negative for minimal residual disease (MRD) within two months of treatment and remained MRD-negative after a median of 15.3 months of follow-up, and none experienced high-grade side effects, according to results presented at the AACR Annual Meeting 2026, held April 17-22, in San Diego, Calif.
For every life-changing new drug that comes to market, many candidates fail along the way. An artificial intelligence-based tool developed at the University of Oregon could help scientists better predict how hypothetical new drugs might act in the body before running expensive tests. Their algorithm efficiently simulates how never-seen-before molecules will move and behave, based on their chemical structure.
When a service encounter goes south, customers expect empathy. Hearing an employee say, “I share your frustration,” can calm tensions and rebuild trust. But new research from the University of South Florida suggests that when a chatbot tries the same tactic, it can backfire.